TWN Info Service on Health Issues (2015)

• WHO: Unease over seconded philanthropic foundation staff to top management
  by TWN (09 Dec 15)
• WHO: Do financial contributions from 'pharma' violate WHO Guidelines?
  by K.M. Gopakumar (07 Dec 15)
• WHO: Expert working group on SSFFC definitions established
  by K.M. Gopakumar (26 Nov 15)
• WHO: Socio-economic impact study of SSFFC medicines is “propaganda”, says South
  by K M Gopakumar (20 Nov 15)
• WHO proposes to join Global Fund's IP enforcement initiative
  by K M Gopakumar (19 Nov 15)
• Iowa Company claims TK useful against antibiotic resistance as its own “invention”
  by Edward Hammond (17 Nov 15)
• Synthetic Biopiracy - Inovio’s Deceptive Influenza Patent Claim
  by Edward Hammond (16 Nov 15)
• TRIPS Council Decision On Extension of the Transition Period Concerning Pharmaceutical Products
  (06 Nov 15)
• Unconditional 17-year exemption from pharmaceuticals patents agreed
  by Sangeeta Shashikant (03 Nov 15)
• WHO: Civil society protest over undermining of current negotiation on FENSA
  (27 Oct 15)
• WHO - Partial agreement on engagement policy with industry
  by K M Gopakumar (26 Oct 15)
• FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie
  (23 Oct 15)
• NGO letter on pharmaceutical transition period for LDCs
  (23 Oct 15)
• Poor countries press for extension of exemption from drug patents
  by Anne Gulland (22 Oct 15)
• "Unconscionable and indefensible" - U.S. 10-year offer to LDCs for pharmaceutical patent waiver
  (21 Oct 15)
• WHO: Secretariat "scare mongering" on FENSA
  by K M Gopakumar (19 Oct 15)
• WHO: Informal meeting to negotiate text on engagement with non-State actors
  by K M Gopakumar (19 Oct 15)
• Some Middle-income Countries Pay More for HepC Drugs than Rich Countries
  (19 Oct 15)
• US stands in the way of LDCs' pharmaceutical transition period
  by Sangeeta Shashikant (15 Oct 15)
• UN Special Rapporteur on right to culture recommends new IP regime for pharmaceuticals
  by K M Gopakumar (12 Oct 15)
• WIPO: Developing countries stress balanced approach to intellectual property
  by Mirza Alas (09 Oct 15)
• MSF seeks int'l probe into Kunduz hospital hit, possible war crime
  by Kanaga Raja (09 Oct 15)
• Press Release: Call on Countries and Parliaments to reject ratification of TPP
  (08 Oct 15)
• Suspension of UNODC work program on model law on fraudulent medicines
  by K M Gopakumar (01 Oct 15)
• Investor-State Arbitration of IP Monopolies on Medicines – Eli Lilly v. Canada and the TPPA
  by Prof. Brook K. Baker & Katrina Geddes (01 Oct 15)
• Don’t let TPP lock Peru into unequal trade
  by Joseph E. Stiglitz & Adam S. Hersh (01 Oct 15)
• Public SDGs or Private GGs?
  by Barbara Adams (25 Sept 15)
• Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
  (25 Sept 15)
• Is the UN fit for the ambitious new Sustainable Development Agenda?
  (23 Sept 15)
• Uruguay abandons TiSA/Uruguay abandona al TiSA
  by Roberto Bissio (10 Sept 15)
• When US, UK doctors refuse to prescribe Indian drugs, it reeks of racism
  by Rema Nagarajan (01 Sept 15)
• Preliminary analysis of biologics exclusivity in the leaked Trans Pacific Partnership Agreement text
  (21 Aug 15)
• South stress balanced approach to patents for public health and development
  by Mirza Alas (04 Aug 15)
• Potential human rights impacts of the TPP (new TWN report)
  (27 Jul 15)
• WIPO Patent law committee to discuss studies on inventive step and disclosure
  by TWN (27 Jul 15)
• WHO negotiations to continue on FENSA
  by K.M. Gopakumar (20 Jul 15)
• Making middle income countries pay full price for drugs is a big mistake
  (20 Jul 15)
• WHO: Concerns that "official relations" are used for promoting business interests
  by TWN (17 Jul 15)
• WHO: Intergovernmental meeting on engagement with non-State actors begins
  by K.M. Gopakumar (09 Jul 15)
• LDC Pharma Extension Request At WTO Yields Support But Needs Further Discussion
  (12 Jun 15)
• WHO Statement on LDC Request for Extension of Pharmaceutical Transition Period
  (12 Jun 15)
• LDC Group's Statement on Its Request for Extension of Pharmaceutical Transition Period
  (12 Jun 15)
• WHO public health, innovation and IP programme to be reviewed
  by K.M. Gopakumar (31 May 15)
• WHO work on non-State actors engagement framework to continue
  by K.M. Gopakumar & Mirza Alas (27 May 15)
• Global antibiotics plan adopted with “kick start” on implementation
  by K.M. Gopakumar & Mirza Alas (27 May 15)
• Antibiotic resistance: A global plan at last
  by Martin Khor (26 May 15)
• CSOs urge support for LDC request on pharmaceuticals exemption
  by Kanaga Raja (26 May 15)
• WHO: Health Assembly steps up Global Vaccine Action Plan implementation
  by Mirza Alas & K.M. Gopakumar (26 May 15)
• How food, beverage giants influence WHO rules
  by Rema Nagarajan (22 May 15)
• Safeguard WHO's Independence From Private Interests, urged public activists
  (22 May 15)
• Anti microbial resistance: India wants access, resources, tech transfer spelt out in global action plan
  by Rema Nagarajan (21 May 15)
• CSOs voice concerns over corporate takeover of WHO
  by Kanaga Raja (21 May 15)
• Did the WHO just invite corporates to set health policy?
  by Chitra Subramaniam (20 May 15)
• Will the World Health Organization survive the Ebola epidemic?
  by German Velasquez (18 May 15)
• Shaping the treaty on business and human rights: Views from Asia and the Pacific
  (11 May 15)
• Access to medicines and the right to health and life: South Centre View
  by Martin Khor (15 Apr 15)
• Study Links Widely Used Pesticides to Antibiotic Resistance
  (26 Mar 15)
  Item 1: Study Links Widely Used Pesticides to Antibiotic Resistance
  Item 2: Common pesticides linked to antibiotic resistance
• Exposure to Herbicides can Cause Change in Bacterial Response to Antibiotics
  (25 Mar 15)
• WTO: LDC request for extension of transition period on pharmaceuticals
  by K. M. Gopakumar (25 Feb 15)
• The registration of biosimilar medicines: lessons from Colombia’s experience
  by German Velasquez (13 Feb 15)
• Environmental Scientists Find Antibiotics, Bacteria, Resistance Genes in Feedlot Dust
  by John Davis (11 Feb 15)
• Access to finance, technology and new medicines to fight AMR needed, says South
  by Mirza Alas (10 Feb 15)
• WHO: Members States propose guidance for engagement with non-State actors
  by Mirza Alas (30 Jan 15)
• WHO: Secretariat ignores requirement of review report on GSPOA
  by K M Gopakumar (29 Jan 15)
• WHO: Critical issues still unresolved in antimicrobial resistance draft action plan
  by Mirza Alas (28 Jan 15)
• No consensus on WHO rules of engagement with non-State actors
  by K M Gopakumar (27 Jan 15)
• WHO: Importance of health system and primacy of WHO stressed
  by K M Gopakumar & Chee Yoke Ling (26 Jan 15)
• WHO capacity on disease outbreaks and emergencies to be enhanced
  by K M Gopakumar (25 Jan 15)